Antineoplastic Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4140645
- 109 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Antineoplastic Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Antineoplastic Drugs market segmented into
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Based on the end-use, the global Antineoplastic Drugs market classified into
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
Based on geography, the global Antineoplastic Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Baxter Healthcare
Boehringer Ingelheim
Aspen Global
Bayer AG
Teva pharmaceutical Industries
Johnson & Johnson
Merc & Co.
Pfize
Accord Healthcare
Genentech
Lundbeck
AbbVie
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANTINEOPLASTIC DRUGS INDUSTRY
2.1 Summary about Antineoplastic Drugs Industry
2.2 Antineoplastic Drugs Market Trends
2.2.1 Antineoplastic Drugs Production & Consumption Trends
2.2.2 Antineoplastic Drugs Demand Structure Trends
2.3 Antineoplastic Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Chemotherapeutic Agents
4.2.2 Biological/Immunotherapeutic Agents
4.2.3 Personalized Medicine
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Cancer Rehabilitation Centers
4.3.4 Ambulatory Surgical Centers
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Chemotherapeutic Agents
5.2.2 Biological/Immunotherapeutic Agents
5.2.3 Personalized Medicine
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Cancer Rehabilitation Centers
5.3.4 Ambulatory Surgical Centers
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Chemotherapeutic Agents
6.2.2 Biological/Immunotherapeutic Agents
6.2.3 Personalized Medicine
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Cancer Rehabilitation Centers
6.3.4 Ambulatory Surgical Centers
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Chemotherapeutic Agents
7.2.2 Biological/Immunotherapeutic Agents
7.2.3 Personalized Medicine
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Cancer Rehabilitation Centers
7.3.4 Ambulatory Surgical Centers
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Chemotherapeutic Agents
8.2.2 Biological/Immunotherapeutic Agents
8.2.3 Personalized Medicine
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Cancer Rehabilitation Centers
8.3.4 Ambulatory Surgical Centers
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Chemotherapeutic Agents
9.2.2 Biological/Immunotherapeutic Agents
9.2.3 Personalized Medicine
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Cancer Rehabilitation Centers
9.3.4 Ambulatory Surgical Centers
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Hoffmann-La Roche
10.1.2 Amgen
10.1.3 Bristol-Myers Squibb
10.1.4 Baxter Healthcare
10.1.5 Boehringer Ingelheim
10.1.6 Aspen Global
10.1.7 Bayer AG
10.1.8 Teva pharmaceutical Industries
10.1.9 Johnson & Johnson
10.1.10 Merc & Co.
10.1.11 Pfize
10.1.12 Accord Healthcare
10.1.13 Genentech
10.1.14 Lundbeck
10.1.15 AbbVie
10.2 Antineoplastic Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Hoffmann-La Roche
10.2.2 Amgen
10.2.3 Bristol-Myers Squibb
10.2.4 Baxter Healthcare
10.2.5 Boehringer Ingelheim
10.2.6 Aspen Global
10.2.7 Bayer AG
10.2.8 Teva pharmaceutical Industries
10.2.9 Johnson & Johnson
10.2.10 Merc & Co.
10.2.11 Pfize
10.2.12 Accord Healthcare
10.2.13 Genentech
10.2.14 Lundbeck
10.2.15 AbbVie
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Antineoplastic Drugs Product Type Overview
Table Antineoplastic Drugs Product Type Market Share List
Table Antineoplastic Drugs Product Type of Major Players
Table Brief Introduction of Hoffmann-La Roche
Table Brief Introduction of Amgen
Table Brief Introduction of Bristol-Myers Squibb
Table Brief Introduction of Baxter Healthcare
Table Brief Introduction of Boehringer Ingelheim
Table Brief Introduction of Aspen Global
Table Brief Introduction of Bayer AG
Table Brief Introduction of Teva pharmaceutical Industries
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Merc & Co.
Table Brief Introduction of Pfize
Table Brief Introduction of Accord Healthcare
Table Brief Introduction of Genentech
Table Brief Introduction of Lundbeck
Table Brief Introduction of AbbVie
Table Products & Services of Hoffmann-La Roche
Table Products & Services of Amgen
Table Products & Services of Bristol-Myers Squibb
Table Products & Services of Baxter Healthcare
Table Products & Services of Boehringer Ingelheim
Table Products & Services of Aspen Global
Table Products & Services of Bayer AG
Table Products & Services of Teva pharmaceutical Industries
Table Products & Services of Johnson & Johnson
Table Products & Services of Merc & Co.
Table Products & Services of Pfize
Table Products & Services of Accord Healthcare
Table Products & Services of Genentech
Table Products & Services of Lundbeck
Table Products & Services of AbbVie
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Antineoplastic Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Antineoplastic Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Antineoplastic Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Antineoplastic Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
